HEIDELBERG PHARMA AG O.N.
HEIDELBERG PHARMA AG O.N./ DE000A11QVV0 /
WL6/D
|
2024-11-15 5:36:11 PM
|
Chg.
-0.060
|
Volume |
Bid2024-11-15 |
Ask2024-11-15 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
2.280EUR
|
-2.56%
|
1,002
Turnover: 2,287.490 |
-Bid Size: - |
-Ask Size: - |
77.92 mill.EUR |
0.00% |
- |
Fundamentals
| |
FY 2021 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
-0.80 EUR |
31.15% |
| EPS Diluted: |
-0.80 EUR |
31.15% |
| Revenues per Share: |
0.05 EUR |
-81.82% |
| Book Value per Share: |
0.20 EUR |
-52.79% |
| Cash Flow per Share: |
-0.78 EUR |
35.06% |
| Dividend per Share: |
0.00 EUR |
- |
| Total |
in mill. |
|
| Revenues: |
1.70 EUR |
-80.00% |
| Net Income: |
-26.10 EUR |
41.85% |
| Operating Cash Flow: |
-26.60 EUR |
- |
| Cash and Cash Equivalents: |
6.10 EUR |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
45.84 |
104.14 |
| P/BV ratio: |
11.63 |
26.42 |
| P/CF Ratio: |
-2.93 |
-6.66 |
| PEG: |
-0.09 |
- |
| Earnings Yield: |
-35.09% |
-15.44% |
| Dividend Yield: |
0.00% |
0.00% |
| Market Capitalization |
|
| Market Capitalization: |
77.92 mill. EUR |
177.03 mill. EUR |
| Free Float Market Cap.: |
53.23 mill. EUR |
120.93 mill. EUR |
| Market Cap. / Employee: |
811,680 EUR |
1.84 mill. EUR |
| Shares Outstanding: |
46.58 mill. |
|
Profitability
| Gross Profit Margin: |
-656.00% |
| EBIT Margin: |
-1,505.88% |
| Net Profit Margin: |
-1,535.29% |
| Return on Equity: |
-389.55% |
| Return on Assets: |
-120.28% |
Financial Strength
| Liquidity I / Cash Ratio: |
40.94% |
| Liquidity II / Quick Ratio: |
47.65% |
| Liquidity III / Current Ratio: |
60.40% |
| Debt / Equity Ratio: |
223.88% |
| Dynam. Debt / Equity Ratio: |
-56.39% |
Efficiency
| Employees: |
96 |
| Personal Expenses / Employee: |
84,916.67 EUR |
| Revenues / Employee: |
17,708.33 EUR |
| Net Income / Employee: |
-271,875.00 EUR |
| Total Assets / Employee: |
226,041.67 EUR |
| * Fiscal Year End: |
2021-11-30 |
| Accounting Standard: |
IFRS |
